Recently, Indian states have repeatedly conducted regulatory reviews on the pharmaceutical industry. Related e-commerce companies urge the government to issue revised regulations as soon as possible to reduce losses.
The bill has not yet been finalized, affecting corporate financing, and employee resignation This bill mainly involves the registration procedures for pharmaceutical e-commerce sellers with the health department. In addition, I hope that the government will require e-commerce sellers to only sell online. Do not hoard drug inventories.
Lanhaiyiguan.com learned that India released a draft drug e-commerce sales regulation in August 2018. At present, stakeholders and government departments have had many rounds of discussions and consultations, and the final regulation has not been announced.
Previously, the Indian Pharmaceutical Technology Consulting Agency also promised the Mumbai High Court to release the revised draft within four months, but there is still no news.
This delay has affected the financing of various pharmaceutical e-commerce companies. Investors are skeptical. They are still waiting and see, and employees have left.
Indian pharmaceutical e-commerce giant 1mg said that since the first joint consultation meeting in June this year, nearly 6 months have passed, and news that the revised bill has been signed. As a stakeholder, 1mg is very happy to see the bill issued as soon as possible.
This year, pharmaceutical e-commerce start-ups have raised 320 million U.S. dollars, and the introduction of industry regulations will increase investment
At present, large pharmaceutical e-commerce sellers have become registered companies and only act as aggregators. Promote all sellers to complete orders.
Indian medicine e-commerce Netmeds created more than 30,000 jobs for industry and attracted more than 700 million US dollars of investment .
In addition, Lanhaiyiguan.com learned that in 2018, Indian pharmaceutical e-commerce start-ups raised 105 million US dollars, and the financing amount reached 320 million US dollars by 2019. Among them, PharmEasy recently raised 220 million US dollars, accounting for the majority of the total investment. .
In short, India's pharmaceutical e-commerce market has a bright future. Of course, if the government formulates corresponding industry policies and regulations, it can not only increase investor confidence, accelerate the development of pharmaceutical e-commerce, but also create a healthy and sustainable development environment for the market. (Blue Ocean Egainnews)
